This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weinstein, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weinstein, M. P.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, July 2001, p. 2729-2731, Vol. 39, No. 7
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.7.2729-2731.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Comparative Evaluation of Penicillin, Ampicillin, and Imipenem MICs and Susceptibility Breakpoints for Vancomycin-Susceptible and Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium

Melvin P. Weinstein*

Departments of Medicine and Pathology, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901-0019

Received 19 January 2001/Returned for modification 28 March 2001/Accepted 3 May 2001

Although imipenem has in vitro activity against Enterococcus faecalis and Food and Drug Administration-approved indications for treatment of infections caused by this microorganism, there are no NCCLS guidelines for susceptibility testing of imipenem versus enterococci. Therefore, the in vitro activities of penicillin, ampicillin, imipenem, and vancomycin against 201 blood isolates of E. faecalis and 24 blood isolates of Enterococcus faecium were compared. The susceptibility of isolates to penicillin or ampicillin accurately predicted the in vitro activity of imipenem. Since the susceptibility of enterococci to imipenem can be predicted by the results obtained by testing of penicillin or ampicillin, testing of imipenem by clinical laboratories probably is not necessary.


* Mailing address: Departments of Medicine and Pathology, UMDNJ-Robert Wood Johnson Medical School, 1 Robert Wood Johnson Pl., New Brunswick, NJ 08901-0019. Phone: (732) 235-7713. Fax: (732) 235-7951. E-mail: weinstei{at}umdnj.edu.


Journal of Clinical Microbiology, July 2001, p. 2729-2731, Vol. 39, No. 7
0095-1137/01/$04.00+0   DOI: 10.1128/JCM.39.7.2729-2731.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Forrest, G. N., Roghmann, M.-C., Toombs, L. S., Johnson, J. K., Weekes, E., Lincalis, D. P., Venezia, R. A. (2008). Peptide Nucleic Acid Fluorescent In Situ Hybridization for Hospital-Acquired Enterococcal Bacteremia: Delivering Earlier Effective Antimicrobial Therapy. Antimicrob. Agents Chemother. 52: 3558-3563 [Abstract] [Full Text]  
  • Metzidie, E., Manolis, E. N., Pournaras, S., Sofianou, D., Tsakris, A. (2006). Spread of an unusual penicillin- and imipenem-resistant but ampicillin-susceptible phenotype among Enterococcus faecalis clinical isolates. J Antimicrob Chemother 57: 158-160 [Full Text]  
  • Weinstein, M. P., Mirrett, S., Kannangara, S., Monahan, J., Harrell, L. J., Wilson, A. C., Reller, L. B. (2004). Multicenter Evaluation of Use of Penicillin and Ampicillin as Surrogates for In Vitro Testing of Susceptibility of Enterococci to Imipenem. J. Clin. Microbiol. 42: 3747-3751 [Abstract] [Full Text]  
  • Lee, H. K., Park, Y.-J., Kwon, H. J., Lee, E. J., Kim, B. K., Kang, C. S. (2004). Evaluation of Vitek System for Susceptibility Testing of Enterococcus faecium Isolates. Annals of Clinical & Laboratory Science 34: 83-86 [Abstract] [Full Text]  
  • El Amin, N., Wretlind, B., Wenger, A., Brandt, V., Bille, J., Weinstein, M. P. (2002). Ampicillin-Sensitive, Imipenem-Resistant Strains of Enterococcus faecium. J. Clin. Microbiol. 40: 738-738 [Full Text]  
  • Jones, R. N. (2001). Prediction of Enterococcal Imipenem Susceptibility Using Ampicillin or Penicillin MICs: More Evidence for a Class Concept. J. Clin. Microbiol. 39: 3810-3811 [Full Text]